U.S. Hospitals Shift to Safer, Cost-Effective Vascular Access Solutions, Pushing Market to $6.9B by 2031 – iData Research

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, BC, May 14, 2025 /PRNewswire/ – A new 2025 Vascular Access Devices Market Report reveals that the U.S. vascular access devices and accessories market is projected to grow from $6 billion in 2024 to nearly $7 billion by 2031, driven by innovations in smart catheters, minimally invasive access devices, and bioactive coatings, as well as the clinical need to reduce complications such as infection and catheter failure.

Produced by iData Research, a leading medical device market intelligence firm, this report offers essential data and strategic insights for medical device executives, product managers, procurement strategists, and infection prevention leaders working in vascular access. It helps stakeholders track the shift to peripheral devices, assess antimicrobial adoption barriers, and understand how smart and needle-free technologies are influencing clinical and purchasing decisions.

“With the U.S. vascular access market nearing $7 billion, hospitals and device companies must act on data to reduce complications and control costs,” said Dr. Kamran Zamanian, CEO of iData Research. “Our report highlights how hospitals are adapting, shifting toward safer, and more cost-effective access solutions that reduce risk and improve reimbursement outcomes.”

Peripheral Devices Gain Ground as Hospitals Prioritize Safety
An estimated 90% of hospitalized patients require some form of vascular access during their stay, and with over 6 million central venous catheter (CVC) insertions annually in the U.S. alone, complications such as bloodstream infections and device failures pose a serious threat to patient safety and hospital budgets.

In response, the U.S. market is shifting toward peripheral alternatives like midlines, extended dwell catheters, and advanced PIVCs, which offer lower complication rates and are easier to manage in outpatient and home-care settings. To boost reliability, manufacturers are improving materials, antimicrobial coatings, and insertion tools, while hospitals increasingly adopt full catheter kits, raising the average selling price across the market.

The U.S. vascular access devices and accessories market, valued at $6 billion in 2024, is projected to reach nearly $7 billion by 2031, shifting toward safer, more cost-effective alternatives such as midlines, extended dwell catheters, and advanced PIVCs.

Key Insights from the Report:

  • Smart IV Catheters & Sensors: Devices with embedded sensors now allow clinicians to monitor infusion parameters in real time, supporting faster interventions and better outcomes.
  • Minimally Invasive Vascular Access Devices: Robotic-assisted PICC insertion and lower-trauma catheter designs are enabling more accurate placement with fewer complications.
  • Needle-Free Systems: Devices using jet or pressure-based access technologies are helping reduce needlestick injuries, particularly in pediatrics and long-term care.
  • Telemonitoring & Remote Management: Integration with remote care platforms is allowing clinicians to monitor device performance outside of hospital settings, helping reduce emergency visits.
  • Bioactive Coatings & Anti-Thrombogenic Materials: Advanced coatings like antimicrobial or heparin-based layers are extending device lifespan and reducing infection and thrombosis rates.

Who Should Read This Report?
This report is designed for product and marketing managers, CEOs, CFOs, as well as strategic decision-makers within vascular access device companies looking to make data-driven decisions in the high-growth vascular access devices (VAD) market.

Explore the Market Report
Access a sample of the 2025 U.S. Vascular Access Devices and Accessories Market Report, or contact marketing at marketing@idataresearch.net to learn more and see detailed insights into market drivers, growth projections, and strategic opportunities.

About iData Research
iData Research has been a leader in market intelligence for the medical device industry for over 20 years, delivering data-driven insights that help companies mitigate market risks, optimize pricing strategies, and uncover new revenue opportunities.

Learn more at https://idataresearch.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/us-hospitals-shift-to-safer-cost-effective-vascular-access-solutions-pushing-market-to-6-9b-by-2031—idata-research-302455274.html

SOURCE iData Research Inc.

Staff

Recent Posts

Flower Expo Returns to Michigan and Illinois This Summer Following Blockbuster Northeast Event

Two-day cannabis trade events will connect brands, dispensaries, and budtenders for networking, product showcases, and…

17 hours ago

Sage Healthspan Launches AI-Powered, Privacy-First Wellness App to Bridge Critical Gaps in Preventative Healthcare

Orange County, California, June 27, 2025 (GLOBE NEWSWIRE) -- Sage Healthspan, a California-based digital health…

17 hours ago

theranos Calls on President Trump to Pardon Elizabeth Holmes

You Cannot Silence the SciencePALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- In less…

17 hours ago

Freeze Drying Equipment Market to Surge from USD 4.9 Billion to USD 8.4 Billion by 2032 – Meticulous Research®

Lyophilization Process Innovation, Food Preservation Demand, and Pharmaceutical Industry Expansion Drive 7.9% CAGR Growth Across…

1 day ago